Please assess the completion status of the following clinical trial:

Trial Title: Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Able to sign Informed Consent and Release of Medical Information Form~* Age ≥ 18 years~* Undergoing cardiac surgery with complete sternotomy (including re-operations)~Exclusion Criteria:~* Evidence of active infection (any culture positive or blood positive infection)~* Undergoing organ transplantation~* Patients with known hypersensitivity to vancomycin~* Pregnant or nursing women~* Mental impairment or other conditions that may not allow participant to understand the nature, significance, and scope of study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vancomycin (Type: EXPERIMENTAL): During open heart surgery, patients will have a 4 x 8 inch piece of sterile gauze covering each side of the divided sternum. The gauze will be soaked in the following solution: 5 g vancomycin dissolved in 50 mL sterile water
- Control (Type: PLACEBO_COMPARATOR): During open heart surgery, patients will have a 4 x 8 inch piece of sterile gauze covering each side of the divided sternum. The gauze will be soaked in 50 mL sterile water. No Vancomycin

Based on this trial design, predict the completion outcome and termination type (if applicable).